0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Monoclonal Antibody Development Services Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17T15380
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Monoclonal Antibody Development Services Market Research Report 2023
BUY CHAPTERS

Global Monoclonal Antibody Development Services Market Research Report 2025

Code: QYRE-Auto-17T15380
Report
May 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Monoclonal Antibody Development Services Market

The global market for Monoclonal Antibody Development Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Monoclonal antibody development services are antibody preparation services tailored to the specific needs of clients. The goal is to generate highly specific and affinity matured monoclonal antibodies for the detection and analysis of specific target molecules. These services are typically provided by specialized antibody development companies, where clients can provide their target antigen or receive guidance to select the most appropriate antigen. The service usually includes immunization of animals with the antigen, hybridoma fusion and screening for monoclonal antibodies, and validation and purification of the monoclonal antibodies. These monoclonal antibodies can be used for various applications, such as immunohistochemistry, immunoblotting, immunoprecipitation, flow cytometry, ELISA, and more.
North American market for Monoclonal Antibody Development Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Monoclonal Antibody Development Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Monoclonal Antibody Development Services in Biopharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Monoclonal Antibody Development Services include Eurogentec, ProSci, Syd Labs, Promab, Antibodies Inc, Bhat Biotech, Synaptic Systems, Covalab, CePower, Lampire Biological Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Development Services.
The Monoclonal Antibody Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoclonal Antibody Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibody Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Monoclonal Antibody Development Services Market Report

Report Metric Details
Report Name Monoclonal Antibody Development Services Market
Segment by Type
  • Small-scale
  • Medium-sclae
  • Large-scale
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurogentec, ProSci, Syd Labs, Promab, Antibodies Inc, Bhat Biotech, Synaptic Systems, Covalab, CePower, Lampire Biological Laboratories, Leinco Technologies, Medimabs, Davids Bioengineering, Scantibodies, Abwiz Bio, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Monoclonal Antibody Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Monoclonal Antibody Development Services Market report?

Ans: The main players in the Monoclonal Antibody Development Services Market are Eurogentec, ProSci, Syd Labs, Promab, Antibodies Inc, Bhat Biotech, Synaptic Systems, Covalab, CePower, Lampire Biological Laboratories, Leinco Technologies, Medimabs, Davids Bioengineering, Scantibodies, Abwiz Bio, Thermo Fisher Scientific

What are the Application segmentation covered in the Monoclonal Antibody Development Services Market report?

Ans: The Applications covered in the Monoclonal Antibody Development Services Market report are Biopharmaceuticals, Medical Diagnosis, Agricultural, Medical Treatment, Environmental monitoring, Others

What are the Type segmentation covered in the Monoclonal Antibody Development Services Market report?

Ans: The Types covered in the Monoclonal Antibody Development Services Market report are Small-scale, Medium-sclae, Large-scale

Recommended Reports

Antibody Development Services

Monoclonal Antibody Markets

Antibody Production Process

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small-scale
1.2.3 Medium-sclae
1.2.4 Large-scale
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Development Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceuticals
1.3.3 Medical Diagnosis
1.3.4 Agricultural
1.3.5 Medical Treatment
1.3.6 Environmental monitoring
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Development Services Market Perspective (2020-2031)
2.2 Global Monoclonal Antibody Development Services Growth Trends by Region
2.2.1 Global Monoclonal Antibody Development Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Monoclonal Antibody Development Services Historic Market Size by Region (2020-2025)
2.2.3 Monoclonal Antibody Development Services Forecasted Market Size by Region (2026-2031)
2.3 Monoclonal Antibody Development Services Market Dynamics
2.3.1 Monoclonal Antibody Development Services Industry Trends
2.3.2 Monoclonal Antibody Development Services Market Drivers
2.3.3 Monoclonal Antibody Development Services Market Challenges
2.3.4 Monoclonal Antibody Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Development Services Players by Revenue
3.1.1 Global Top Monoclonal Antibody Development Services Players by Revenue (2020-2025)
3.1.2 Global Monoclonal Antibody Development Services Revenue Market Share by Players (2020-2025)
3.2 Global Monoclonal Antibody Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Monoclonal Antibody Development Services Revenue
3.4 Global Monoclonal Antibody Development Services Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Development Services Revenue in 2024
3.5 Global Key Players of Monoclonal Antibody Development Services Head office and Area Served
3.6 Global Key Players of Monoclonal Antibody Development Services, Product and Application
3.7 Global Key Players of Monoclonal Antibody Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Development Services Breakdown Data by Type
4.1 Global Monoclonal Antibody Development Services Historic Market Size by Type (2020-2025)
4.2 Global Monoclonal Antibody Development Services Forecasted Market Size by Type (2026-2031)
5 Monoclonal Antibody Development Services Breakdown Data by Application
5.1 Global Monoclonal Antibody Development Services Historic Market Size by Application (2020-2025)
5.2 Global Monoclonal Antibody Development Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Monoclonal Antibody Development Services Market Size (2020-2031)
6.2 North America Monoclonal Antibody Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Monoclonal Antibody Development Services Market Size by Country (2020-2025)
6.4 North America Monoclonal Antibody Development Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Development Services Market Size (2020-2031)
7.2 Europe Monoclonal Antibody Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Monoclonal Antibody Development Services Market Size by Country (2020-2025)
7.4 Europe Monoclonal Antibody Development Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Development Services Market Size (2020-2031)
8.2 Asia-Pacific Monoclonal Antibody Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Monoclonal Antibody Development Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Monoclonal Antibody Development Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Development Services Market Size (2020-2031)
9.2 Latin America Monoclonal Antibody Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Monoclonal Antibody Development Services Market Size by Country (2020-2025)
9.4 Latin America Monoclonal Antibody Development Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Development Services Market Size (2020-2031)
10.2 Middle East & Africa Monoclonal Antibody Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Monoclonal Antibody Development Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Monoclonal Antibody Development Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurogentec
11.1.1 Eurogentec Company Details
11.1.2 Eurogentec Business Overview
11.1.3 Eurogentec Monoclonal Antibody Development Services Introduction
11.1.4 Eurogentec Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.1.5 Eurogentec Recent Development
11.2 ProSci
11.2.1 ProSci Company Details
11.2.2 ProSci Business Overview
11.2.3 ProSci Monoclonal Antibody Development Services Introduction
11.2.4 ProSci Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.2.5 ProSci Recent Development
11.3 Syd Labs
11.3.1 Syd Labs Company Details
11.3.2 Syd Labs Business Overview
11.3.3 Syd Labs Monoclonal Antibody Development Services Introduction
11.3.4 Syd Labs Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.3.5 Syd Labs Recent Development
11.4 Promab
11.4.1 Promab Company Details
11.4.2 Promab Business Overview
11.4.3 Promab Monoclonal Antibody Development Services Introduction
11.4.4 Promab Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.4.5 Promab Recent Development
11.5 Antibodies Inc
11.5.1 Antibodies Inc Company Details
11.5.2 Antibodies Inc Business Overview
11.5.3 Antibodies Inc Monoclonal Antibody Development Services Introduction
11.5.4 Antibodies Inc Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.5.5 Antibodies Inc Recent Development
11.6 Bhat Biotech
11.6.1 Bhat Biotech Company Details
11.6.2 Bhat Biotech Business Overview
11.6.3 Bhat Biotech Monoclonal Antibody Development Services Introduction
11.6.4 Bhat Biotech Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.6.5 Bhat Biotech Recent Development
11.7 Synaptic Systems
11.7.1 Synaptic Systems Company Details
11.7.2 Synaptic Systems Business Overview
11.7.3 Synaptic Systems Monoclonal Antibody Development Services Introduction
11.7.4 Synaptic Systems Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.7.5 Synaptic Systems Recent Development
11.8 Covalab
11.8.1 Covalab Company Details
11.8.2 Covalab Business Overview
11.8.3 Covalab Monoclonal Antibody Development Services Introduction
11.8.4 Covalab Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.8.5 Covalab Recent Development
11.9 CePower
11.9.1 CePower Company Details
11.9.2 CePower Business Overview
11.9.3 CePower Monoclonal Antibody Development Services Introduction
11.9.4 CePower Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.9.5 CePower Recent Development
11.10 Lampire Biological Laboratories
11.10.1 Lampire Biological Laboratories Company Details
11.10.2 Lampire Biological Laboratories Business Overview
11.10.3 Lampire Biological Laboratories Monoclonal Antibody Development Services Introduction
11.10.4 Lampire Biological Laboratories Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.10.5 Lampire Biological Laboratories Recent Development
11.11 Leinco Technologies
11.11.1 Leinco Technologies Company Details
11.11.2 Leinco Technologies Business Overview
11.11.3 Leinco Technologies Monoclonal Antibody Development Services Introduction
11.11.4 Leinco Technologies Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.11.5 Leinco Technologies Recent Development
11.12 Medimabs
11.12.1 Medimabs Company Details
11.12.2 Medimabs Business Overview
11.12.3 Medimabs Monoclonal Antibody Development Services Introduction
11.12.4 Medimabs Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.12.5 Medimabs Recent Development
11.13 Davids Bioengineering
11.13.1 Davids Bioengineering Company Details
11.13.2 Davids Bioengineering Business Overview
11.13.3 Davids Bioengineering Monoclonal Antibody Development Services Introduction
11.13.4 Davids Bioengineering Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.13.5 Davids Bioengineering Recent Development
11.14 Scantibodies
11.14.1 Scantibodies Company Details
11.14.2 Scantibodies Business Overview
11.14.3 Scantibodies Monoclonal Antibody Development Services Introduction
11.14.4 Scantibodies Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.14.5 Scantibodies Recent Development
11.15 Abwiz Bio
11.15.1 Abwiz Bio Company Details
11.15.2 Abwiz Bio Business Overview
11.15.3 Abwiz Bio Monoclonal Antibody Development Services Introduction
11.15.4 Abwiz Bio Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.15.5 Abwiz Bio Recent Development
11.16 Thermo Fisher Scientific
11.16.1 Thermo Fisher Scientific Company Details
11.16.2 Thermo Fisher Scientific Business Overview
11.16.3 Thermo Fisher Scientific Monoclonal Antibody Development Services Introduction
11.16.4 Thermo Fisher Scientific Revenue in Monoclonal Antibody Development Services Business (2020-2025)
11.16.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Monoclonal Antibody Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Small-scale
 Table 3. Key Players of Medium-sclae
 Table 4. Key Players of Large-scale
 Table 5. Global Monoclonal Antibody Development Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Monoclonal Antibody Development Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Monoclonal Antibody Development Services Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Monoclonal Antibody Development Services Market Share by Region (2020-2025)
 Table 9. Global Monoclonal Antibody Development Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Monoclonal Antibody Development Services Market Share by Region (2026-2031)
 Table 11. Monoclonal Antibody Development Services Market Trends
 Table 12. Monoclonal Antibody Development Services Market Drivers
 Table 13. Monoclonal Antibody Development Services Market Challenges
 Table 14. Monoclonal Antibody Development Services Market Restraints
 Table 15. Global Monoclonal Antibody Development Services Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Monoclonal Antibody Development Services Market Share by Players (2020-2025)
 Table 17. Global Top Monoclonal Antibody Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Development Services as of 2024)
 Table 18. Ranking of Global Top Monoclonal Antibody Development Services Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Monoclonal Antibody Development Services Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Monoclonal Antibody Development Services, Headquarters and Area Served
 Table 21. Global Key Players of Monoclonal Antibody Development Services, Product and Application
 Table 22. Global Key Players of Monoclonal Antibody Development Services, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Monoclonal Antibody Development Services Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Monoclonal Antibody Development Services Revenue Market Share by Type (2020-2025)
 Table 26. Global Monoclonal Antibody Development Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Monoclonal Antibody Development Services Revenue Market Share by Type (2026-2031)
 Table 28. Global Monoclonal Antibody Development Services Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Monoclonal Antibody Development Services Revenue Market Share by Application (2020-2025)
 Table 30. Global Monoclonal Antibody Development Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Monoclonal Antibody Development Services Revenue Market Share by Application (2026-2031)
 Table 32. North America Monoclonal Antibody Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Monoclonal Antibody Development Services Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Monoclonal Antibody Development Services Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Monoclonal Antibody Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Monoclonal Antibody Development Services Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Monoclonal Antibody Development Services Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Monoclonal Antibody Development Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Monoclonal Antibody Development Services Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Monoclonal Antibody Development Services Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Monoclonal Antibody Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Monoclonal Antibody Development Services Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Monoclonal Antibody Development Services Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Monoclonal Antibody Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Monoclonal Antibody Development Services Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Monoclonal Antibody Development Services Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Eurogentec Company Details
 Table 48. Eurogentec Business Overview
 Table 49. Eurogentec Monoclonal Antibody Development Services Product
 Table 50. Eurogentec Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 51. Eurogentec Recent Development
 Table 52. ProSci Company Details
 Table 53. ProSci Business Overview
 Table 54. ProSci Monoclonal Antibody Development Services Product
 Table 55. ProSci Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 56. ProSci Recent Development
 Table 57. Syd Labs Company Details
 Table 58. Syd Labs Business Overview
 Table 59. Syd Labs Monoclonal Antibody Development Services Product
 Table 60. Syd Labs Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 61. Syd Labs Recent Development
 Table 62. Promab Company Details
 Table 63. Promab Business Overview
 Table 64. Promab Monoclonal Antibody Development Services Product
 Table 65. Promab Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 66. Promab Recent Development
 Table 67. Antibodies Inc Company Details
 Table 68. Antibodies Inc Business Overview
 Table 69. Antibodies Inc Monoclonal Antibody Development Services Product
 Table 70. Antibodies Inc Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 71. Antibodies Inc Recent Development
 Table 72. Bhat Biotech Company Details
 Table 73. Bhat Biotech Business Overview
 Table 74. Bhat Biotech Monoclonal Antibody Development Services Product
 Table 75. Bhat Biotech Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 76. Bhat Biotech Recent Development
 Table 77. Synaptic Systems Company Details
 Table 78. Synaptic Systems Business Overview
 Table 79. Synaptic Systems Monoclonal Antibody Development Services Product
 Table 80. Synaptic Systems Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 81. Synaptic Systems Recent Development
 Table 82. Covalab Company Details
 Table 83. Covalab Business Overview
 Table 84. Covalab Monoclonal Antibody Development Services Product
 Table 85. Covalab Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 86. Covalab Recent Development
 Table 87. CePower Company Details
 Table 88. CePower Business Overview
 Table 89. CePower Monoclonal Antibody Development Services Product
 Table 90. CePower Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 91. CePower Recent Development
 Table 92. Lampire Biological Laboratories Company Details
 Table 93. Lampire Biological Laboratories Business Overview
 Table 94. Lampire Biological Laboratories Monoclonal Antibody Development Services Product
 Table 95. Lampire Biological Laboratories Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 96. Lampire Biological Laboratories Recent Development
 Table 97. Leinco Technologies Company Details
 Table 98. Leinco Technologies Business Overview
 Table 99. Leinco Technologies Monoclonal Antibody Development Services Product
 Table 100. Leinco Technologies Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 101. Leinco Technologies Recent Development
 Table 102. Medimabs Company Details
 Table 103. Medimabs Business Overview
 Table 104. Medimabs Monoclonal Antibody Development Services Product
 Table 105. Medimabs Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 106. Medimabs Recent Development
 Table 107. Davids Bioengineering Company Details
 Table 108. Davids Bioengineering Business Overview
 Table 109. Davids Bioengineering Monoclonal Antibody Development Services Product
 Table 110. Davids Bioengineering Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 111. Davids Bioengineering Recent Development
 Table 112. Scantibodies Company Details
 Table 113. Scantibodies Business Overview
 Table 114. Scantibodies Monoclonal Antibody Development Services Product
 Table 115. Scantibodies Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 116. Scantibodies Recent Development
 Table 117. Abwiz Bio Company Details
 Table 118. Abwiz Bio Business Overview
 Table 119. Abwiz Bio Monoclonal Antibody Development Services Product
 Table 120. Abwiz Bio Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 121. Abwiz Bio Recent Development
 Table 122. Thermo Fisher Scientific Company Details
 Table 123. Thermo Fisher Scientific Business Overview
 Table 124. Thermo Fisher Scientific Monoclonal Antibody Development Services Product
 Table 125. Thermo Fisher Scientific Revenue in Monoclonal Antibody Development Services Business (2020-2025) & (US$ Million)
 Table 126. Thermo Fisher Scientific Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. Monoclonal Antibody Development Services Picture
 Figure 2. Global Monoclonal Antibody Development Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Monoclonal Antibody Development Services Market Share by Type: 2024 VS 2031
 Figure 4. Small-scale Features
 Figure 5. Medium-sclae Features
 Figure 6. Large-scale Features
 Figure 7. Global Monoclonal Antibody Development Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Monoclonal Antibody Development Services Market Share by Application: 2024 VS 2031
 Figure 9. Biopharmaceuticals Case Studies
 Figure 10. Medical Diagnosis Case Studies
 Figure 11. Agricultural Case Studies
 Figure 12. Medical Treatment Case Studies
 Figure 13. Environmental monitoring Case Studies
 Figure 14. Others Case Studies
 Figure 15. Monoclonal Antibody Development Services Report Years Considered
 Figure 16. Global Monoclonal Antibody Development Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Monoclonal Antibody Development Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Monoclonal Antibody Development Services Market Share by Region: 2024 VS 2031
 Figure 19. Global Monoclonal Antibody Development Services Market Share by Players in 2024
 Figure 20. Global Top Monoclonal Antibody Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Development Services as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Monoclonal Antibody Development Services Revenue in 2024
 Figure 22. North America Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Monoclonal Antibody Development Services Market Share by Country (2020-2031)
 Figure 24. United States Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Monoclonal Antibody Development Services Market Share by Country (2020-2031)
 Figure 28. Germany Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Monoclonal Antibody Development Services Market Share by Region (2020-2031)
 Figure 36. China Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Monoclonal Antibody Development Services Market Share by Country (2020-2031)
 Figure 44. Mexico Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Monoclonal Antibody Development Services Market Share by Country (2020-2031)
 Figure 48. Turkey Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Monoclonal Antibody Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Eurogentec Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 52. ProSci Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 53. Syd Labs Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 54. Promab Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 55. Antibodies Inc Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 56. Bhat Biotech Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 57. Synaptic Systems Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 58. Covalab Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 59. CePower Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 60. Lampire Biological Laboratories Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 61. Leinco Technologies Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 62. Medimabs Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 63. Davids Bioengineering Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 64. Scantibodies Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 65. Abwiz Bio Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Monoclonal Antibody Development Services Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String